Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate effect on Etonogestrel levels
NCT03335163Phase 1Completed
- Sponsor
- University of Colorado Denver
- Start
- Mar 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of topiramate in migraine, sponsored by University of Colorado Denver. Primary endpoint: Serum Etonogestrel Concentrations at 6 weeks. Started Mar 2018; status: completed.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03335163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03335163.